The impact of acquired brain damage in terms of epidemiology, economics and loss in quality of life

BMC Neurology

Volumn 11, Issue , 2011, Pages

  Mar, Javier ^a   Arrospide, Arantzazu ^a   Begiristain, José M ^b   Larrañaga, Isabel ^b   Elosegui, Elena ^b   Oliva Moreno, Juan ^c  

^a Hospital Alto Deba   (Spain)

^b Gipuzkoa Regional Office for Health   (Spain)

^c UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN DAMAGE; DISABILITY; FEMALE; HEALTH CARE COST; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; QUALITY OF LIFE; SHORT FORM 36; STROKE; AGE; BRAIN; BRAIN INJURY; CROSS-SECTIONAL STUDY; ECONOMICS; HEALTH STATUS; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SPAIN; THEORETICAL MODEL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN; BRAIN INJURIES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; QUALITY OF LIFE; QUESTIONNAIRES; SPAIN; STROKE;

EID: 79955082101     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-11-46     Document Type: Article

References (37)

1. Rothwell PM. The high cost of not funding stroke research: a comparison with heart disease and cancer. Lancet 2001, 357:1612-1616. 10.1016/S0140-6736(00)04730-9, 11377668.
2. Ommaya AK, Ommaya AK, Dannenberg AL, Salazar AM. Causation, incidence, and costs of traumatic brain injury in the U.S. military medical system. J Trauma 1996, 40:211-217. 10.1097/00005373-199602000-00007, 8637068.
3. McGarry LJ, Thompson D, Millham FH, Cowell L, Snyder PJ, Lenderking WR, Weinstein MC. Outcomes and costs of acute treatment of traumatic brain injury. J Trauma 2002, 53:1152-1159. 10.1097/00005373-200212000-00020, 12478043.
4. Kayani NA, Homan S, Yun S, Zhu BP. Health and economic burden of traumatic brain injury: Missouri, 2001-2005. Public Health Rep 2009, 124:551-560.
5. Evers SM, Struijs JN, Ament AJ, van Genugten ML, Jager JH, van den Bos GA. International comparison of stroke cost studies. Stroke 2004, 35:1209-1215. 10.1161/01.STR.0000125860.48180.48, 15073405.
6. Youman P, Wilson K, Harraf F, Kalra L. The economic burden of stroke in the United Kingdom. Pharmacoeconomics 2003, 21(suppl 1):43-50. 10.2165/00019053-200321001-00005, 12648034.
7. Arrazola A, Begiristain JM, Mar J. Hospital care of cerebrovascular accident and the state of patients 12 months after. 2005. Rev Neurol 2005, 40:326-30.
8. Hankey GJ. Stroke treatment and prevention: an evidence-based approach. 2005, 1-8. New York: Cambridge University Press.
9. Langton Hewer R, Tennant A. The epidemiology of disabling neurological disorders. Handbook of neurological rehabilitation 2003, 5-14. Hove: Psychology Press, Greenwood RJ, Barnes MP, McMillan TM, Ward CD.
10. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997, 349:1436-42. 10.1016/S0140-6736(96)07495-8, 9164317.
11. Knapp M, Prince M. Dementia UK: the full report 2007, London, Alzheimer's Society.
12. Comas M, Castells X, Hoffmeister L, Roman R, Cots F, Mar J, Gutierrez-Moreno S, Espallargues M. Discrete-event simulation applied to the analysis of waiting lists. Evaluation of a prioritization system for cataract surgery. Value Health 2008, 11:1203-1213. 10.1111/j.1524-4733.2008.00322.x, 18494754.
13. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md Med J 1965, 14:61-65.
14. Lawton MP, Brody EM. Assessment of older people: self maintaining and instrumental activities of daily living. Gerontologist 1969, 9:179-186.
15. Ware JR, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I conceptual framework and item selection. Med Care 1992, 30:473-483. 10.1097/00005650-199206000-00002, 1593914.
16. EuroQoL Group EuroQoL - A new facility for measurement of health -related quality of life. Health Policy 1990, 16:199-208. 10.1016/0168-8510(90)90421-9, 10109801, EuroQoL Group.
17. Drummond MF, O'Brien B, Stoddard G, Torrance GW. Methods for the economic evaluation of health care programmes. 1997, 52-95. Oxford: Oxford University Press, 2.
18. Hervas A, Forcén T. Coste del cuidado informal del ictus en una población general no institucionalizada. Gac Sanitaria 2007, 21:444-451.
19. Encuesta española Encuesta trimestral de Coste Laboral (ETCL 2008). Instituto Nacional de Estadística., http://www.ine.es/jaxi/menu.do?type=pcaxis&path=%2Ft22/p187&file=inebase&L=0
20. Badía X, Roset M, Montserrat S, Herdman M, Segura A. La versión española del EuroQol: descripción y aplicaciones. Med Clin (Barc) 1999, 112(suppl 1):S79-S86.
21. Alonso J, Prieto L, Antó JM. La versión española del SF-36 Health Survey (Cuestionario de salud SF-36): un instrumento para la medida de los resultados clínicos. Med Clin (Barc) 1995, 104:771-776.
22. Encuesta de Salud del País Vasco (ESCAV 2002). Departamento de Sanidad, Gobierno Vasco., http://www.osasun.ejgv.euskadi.net/r52-20726/es/contenidos/informacion/encuesta_salud/es_4044/encues_salud.html
23. Cohen J. Statistical power analysis for the behavioural sciences. 1977, 8. New York: Academic Press.
24. Mar J, Sainz-Ezkerra M, Moler-Cuiral JA. Calculation of prevalence estimates through differential equations: Application to stroke-related disability. Neuroepidemiology 2008, 31:57-66. 10.1159/000140096, 18560244.
25. Mar J, Arrospide A, Comas M. Budget Impact Analysis of Thrombolysis for Stroke in Spain: A Discrete Event Simulation Model. Value Health 2010, 13:69-76. 10.1111/j.1524-4733.2009.00655.x, 19818059.
26. Kelton WD, Sadowski RP, Sturrock DT. Simulation with ARENA. 2007, New York, McGraw Hill.
27. Rothman KJ, Greenland S. Measures of disease frequency. Modern Epidemiology 1998, 29-46. Philadelphia: Lippincott, Williams and Wilkins, Rothman KJ, Greenland S.
28. Hilden J. Budget impact analysis and its rational basis. Med Decis Making 2008, 28:461-2.
29. López-Bastida J, Perestelo-Pérez L, Montón-Álvarez F, Serrano-Aguilar P. Social economic costs and health-related quality of life in patients with degenerative cerebellar ataxia in Spain. Movement Disorders 2008, 23:212-217.
30. López-Bastida J, Oliva-Moreno J, Perestelo-Pérez L, Serrano-Aguilar P. The economic costs and health-related quality of life of people with HIV/AIDS in the Canary Islands, Spain. BMC Health Serv Res 2009, 9:55. 2670289, 19331682.
31. López-Bastida J, Serrano-Aguilar P, Perestelo-Pérez L, Oliva-Moreno J. Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain. Neurology 2006, 67:2186-2191.
32. van den Berg B, Brouwer W, van Exel J, Koopmanschap M, van den Bos GA, Rutten F. Economic valuation of informal care: lessons from the application of the opportunity costs and proxy good methods. Soc Sci Med 2006, 62:835-845. 10.1016/j.socscimed.2005.06.046, 16137814.
33. van den Berg B, Brouwer W, Koopmanschap M. Economic valuation of informal care: An overview of methods and applications. Eur J Health Econ 2004, 5:36-45. 10.1007/s10198-003-0189-y, 15452763.
34. Comas-Herrera A, Wittenberg R, Costa-Font J, Gori C, Di Maio A, Patxot C, et al. Future Long-Term Care Expenditure in Germany, Spain, Italy and the United Kingdom. Ageing Soc 2006, 26:285-302.
35. Hu TW. Perspectives: an international review of the national cost estimates of mental illness, 1990-2003. J Ment Health Policy Econ 2006, 9:3-13.
36. Consejo Interterritorial del Sistema Nacional de Salud Estrategia en ictus del Sistema Nacional de Salud. 2009, Madrid: Ministerio de Sanidad y Consumo, Consejo Interterritorial del Sistema Nacional de Salud.
37. Oliva J, López-Bastida J, Montejo AL, Osuna R, Duque B. The socioeconomic costs of mental illness in Spain. Eur J Health Econ 2009, 10:361-369. 10.1007/s10198-008-0135-0, 19031056.